Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced it has entered into a collaboration with Mayo Clinic to integrate the organization’s educational content on overactive bladder (OAB), into Axena Health’s clinically proven Leva® Pelvic Health System.

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced the appointment of Erica Rogers to its Board of Directors. Known for her transformative leadership in the medical device industry, Rogers brings over two decades of expertise

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, today announced the appointment of Randy Pritchard as its new Chief Executive Officer, effective immediately. Pritchard brings nearly 25 years of experience in medical device and health technology, including leadership in driving commercial success, innovation, and strategic opportunities

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that the National Institutes of Health’s (NIH) Pelvic Floor Disorders Network (PFDN) will include the Leva® Pelvic Health System in a multi-center clinical study

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that a new published study adds additional real-world evidence supporting women’s effective use of the Leva® Pelvic Health System to access pelvic floor muscle training (PFMT), which is first-line treatment for incontinence.

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has closed on an additional $9.4 million in its Series A fundraising.

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, unveiled the findings from a landmark study to understand the impact of urinary incontinence (UI) on women in sub-Saharan Africa.

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, welcomes the Centers for Medicare & Medicaid Services’ (CMS) new Healthcare Common Procedure Coding System (HCPCS) Level II code for the Leva® Pelvic Health System.

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, announced today that leading pelvic health researchers have published a new study demonstrating the Leva® Pelvic Health System’s long-term treatment efficacy for female urinary incontinence (UI).

Axena Health, Inc. (Axena Health), a medical device company focused on female pelvic health, has launched a study to examine the barriers women faced while seeking treatment for urinary incontinence (UI) and fecal incontinence (FI).